Erratum to: Phase II dose–response study of abatacept in Japanese patients with active rheumatoid arthritis with an inadequate response to methotrexate

Takeuchi, Tsutomu; Matsubara, Tsukasa; Nitobe, Taisuke; Suematsu, Eiichi; Ohta, Syuji; Honjo, Shigeru; Abe, Tohru; Yamamoto, Ami; Miyasaka, Nobuyuki

doi:10.1007/s10165-012-0798-3

Erratum to: Phase II dose–response study of abatacept in Japanese patients with active rheumatoid arthritis with an inadequate response to methotrexate

Erratum
Published: 19 November 2012

Volume 23, page 236, (2013)
Cite this article

Download PDF

Modern Rheumatology

Erratum to: Phase II dose–response study of abatacept in Japanese patients with active rheumatoid arthritis with an inadequate response to methotrexate

Download PDF

Tsutomu Takeuchi¹,
Tsukasa Matsubara²,
Taisuke Nitobe³,
Eiichi Suematsu⁴,
Syuji Ohta⁵,
Shigeru Honjo⁶,
Tohru Abe⁷,
Ami Yamamoto⁸,
Nobuyuki Miyasaka⁹ &
The Japan Abatacept Study Group

2100 Accesses
Explore all metrics

The Original Article was published on 09 June 2012

Erratum to: Mod Rheumatol DOI 10.1007/s10165-012-0668-z

The correct affiliation of Taisuke Nitobe is Department of Orthopedics, Seihoku Chuoh Hospital, 41 Nunoyacho, Goshogawara, Aomori 037-0053, Japan. The authors apologize for any inconvenience this error may have caused.

Author information

Authors and Affiliations

Division of Rheumatology, Department of Internal Medicine, School of Medicine, Keio University, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan
Tsutomu Takeuchi
Department of Orthopedics, Matsubara Mayflower Hospital, 944-25 Fujita, Kato, Hyogo, 673-1462, Japan
Tsukasa Matsubara
Department of Orthopedics, Seihoku Chuoh Hospital, 41 Nunoyacho, Goshogawara, Aomori, 037-0053, Japan
Taisuke Nitobe
Department of Internal Medicine and Rheumatology, National Hospital Organization Kyushu Medical Center, 1-8-1 Jigyohama, Chuo-ku, Fukuoka, 810-8563, Japan
Eiichi Suematsu
Department of Rheumatology, Taga General Hospital, 2-1-2 Kokubun-cho, Hitachi, Ibaraki, 316-0035, Japan
Syuji Ohta
Honjo Rheumatism Clinic, 387-1 Futatsuka, Takaoka, Toyama, 933-8525, Japan
Shigeru Honjo
Division of Rheumatology, Clinical Immunology, Saitama Medical Center/School, 1981 Kamoda, Kawagoe, Saitama, 350-8550, Japan
Tohru Abe
Bristol-Myers KK, 6-5-1, Nishi-shinjuku, Shinjuku-ku, Tokyo, 163-1328, Japan
Ami Yamamoto
Department of Medicine and Rheumatology and Global Center of Excellence, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, 1-5-45 Yusima, Bunkyo-ku, Tokyo, 113-8519, Japan
Nobuyuki Miyasaka

Authors

Tsutomu Takeuchi
View author publications
You can also search for this author in PubMed Google Scholar
Tsukasa Matsubara
View author publications
You can also search for this author in PubMed Google Scholar
Taisuke Nitobe
View author publications
You can also search for this author in PubMed Google Scholar
Eiichi Suematsu
View author publications
You can also search for this author in PubMed Google Scholar
Syuji Ohta
View author publications
You can also search for this author in PubMed Google Scholar
Shigeru Honjo
View author publications
You can also search for this author in PubMed Google Scholar
Tohru Abe
View author publications
You can also search for this author in PubMed Google Scholar
Ami Yamamoto
View author publications
You can also search for this author in PubMed Google Scholar
Nobuyuki Miyasaka
View author publications
You can also search for this author in PubMed Google Scholar

Consortia

The Japan Abatacept Study Group

Corresponding author

Correspondence to Tsutomu Takeuchi.

Additional information

The online version of the original article can be found under doi:10.1007/s10165-012-0668-z.

About this article

Cite this article

Takeuchi, T., Matsubara, T., Nitobe, T. et al. Erratum to: Phase II dose–response study of abatacept in Japanese patients with active rheumatoid arthritis with an inadequate response to methotrexate. Mod Rheumatol 23, 236 (2013). https://doi.org/10.1007/s10165-012-0798-3

Download citation

Published: 19 November 2012
Issue Date: March 2013
DOI: https://doi.org/10.1007/s10165-012-0798-3

Use our pre-submission checklist

Avoid common mistakes on your manuscript.

Erratum to: Phase II dose–response study of abatacept in Japanese patients with active rheumatoid arthritis with an inadequate response to methotrexate

Erratum to: Mod Rheumatol DOI 10.1007/s10165-012-0668-z

Author information

Authors and Affiliations

Consortia

The Japan Abatacept Study Group

Corresponding author

Additional information

About this article

Cite this article

Share this article

Search

Navigation